CBD Improved Memory After Brain Injury by Activating a Novel Protective Pathway | Research

The takeaway

CBD improved cognitive impairment after traumatic brain injury in mice by directly binding to the SET protein, activating a new protective signaling pathway (SET/PP2A/Akt) that reduces brain cell death.

TBI patients and caregivers, neurologists, neuroscience researchers, and anyone interested in CBD's mechanisms beyond cannabinoid receptors.

What the researchers found

CBD inhibited neuronal oxidative stress and apoptosis both in vivo and in vitro. CBD directly bound to the SET protein, inducing conformational changes that kept it in the cytoplasm, which suppressed PP2A activity and activated the Akt survival pathway. This novel SET/PP2A/Akt mechanism provides a new drug target for TBI-related cognitive impairment.

Why it matters

Traumatic brain injury is a leading cause of cognitive disability with no effective treatments for the cognitive aftermath. Discovering that CBD works through a previously unknown mechanism (SET/PP2A/Akt) opens an entirely new therapeutic target.

The numbers in context

CBD reduced oxidative stress and apoptosis in vitro and in vivo. Novel mechanism: CBD → binds SET protein → conformational change → cytoplasmic retention → PP2A suppression → Akt activation → neuroprotection. Multiple validation methods: CETSA, SPR, molecular dynamics confirmed direct binding.

How the study worked

Preclinical study using both in vitro H2O2 neuronal oxidative stress model and in vivo controlled cortical impact TBI model. Comprehensive mechanistic investigation using Western blot, histology, biochemistry, RNA-Seq, co-immunoprecipitation, molecular dynamics, CETSA, SPR, and immunofluorescence.

What this study cannot tell us

Mouse model of TBI doesn't perfectly replicate human injury. CBD dose optimization for human TBI unknown. Single mechanism studied — TBI involves multiple pathological processes. Long-term outcomes not assessed.

How to read the evidence

Rigorous preclinical study with multiple validation methods for the novel mechanism, but animal data only with no human translation yet.

When this study was published

Published in 2026, identifying a previously unknown CBD mechanism of action.

The bigger picture

Most CBD research focuses on cannabinoid receptors, but this study reveals CBD works through a completely different target (SET protein) for neuroprotection. This could explain some of CBD's beneficial effects that don't involve traditional cannabinoid signaling.

Questions still open

Could targeting the SET/PP2A/Akt pathway lead to new TBI drugs? Would CBD given after human TBI improve cognitive outcomes? Is this mechanism relevant to other neurodegenerative conditions?

Common questions

Could CBD help after a concussion or brain injury?

In mice, CBD improved cognitive impairment after TBI by protecting brain cells through a newly discovered pathway. However, this hasn't been tested in humans yet, and the optimal timing and dose are unknown.

How does CBD protect the brain after injury?

This study found CBD directly binds to a protein called SET, which triggers a chain reaction (SET/PP2A/Akt) that reduces oxidative stress and prevents brain cell death. This is different from how CBD is typically thought to work through cannabinoid receptors.

Read the original research

Cannabidiol improves cognitive impairment after traumatic brain injury by attenuating neuronal oxidative stress and apoptosis via the SET/PP2A/Akt signaling axis.

Phytomedicine : international journal of phytotherapy and phytopharmacology, 150, 157769

View on PubMed ↗Publisher’s paper ↗

Citation

Gao, Shan; Xiao, Zhennan; Liu, Hongtao. (2026). Cannabidiol improves cognitive impairment after traumatic brain injury by attenuating neuronal oxidative stress and apoptosis via the SET/PP2A/Akt signaling axis.. Phytomedicine : international journal of phytotherapy and phytopharmacology, 150, 157769. https://doi.org/10.1016/j.phymed.2026.157769